Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zoetis
(NY:
ZTS
)
123.23
+2.25 (+1.86%)
Official Closing Price
Updated: 4:10 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zoetis
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Why Zoetis Stock Was Falling Today
↗
February 13, 2025
Via
The Motley Fool
What's going on in today's session: S&P500 gap up and gap down stocks
↗
February 13, 2025
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via
Chartmill
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
↗
February 13, 2025
ZTS earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Zoetis Earnings Top Analysts' Forecasts
↗
February 13, 2025
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments.
Via
The Motley Fool
Zoetis Drops As 2025 Guidance Falls Short Of Estimates
↗
February 13, 2025
Zoetis posted Q4 earnings above estimates with strong organic growth. 2025 guidance signals lower-than-expected revenue and EPS, sending shares down.
Via
Benzinga
Zoetis Plunges 9% As 2025 Guidance Misses Expectations
↗
February 13, 2025
The company topped fourth-quarter expectations, but guidance was no treat.
Via
Investor's Business Daily
Earnings Scheduled For February 13, 2025
↗
February 13, 2025
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
January 20, 2025
Via
Benzinga
How Is The Market Feeling About Zoetis?
↗
January 10, 2025
Via
Benzinga
Which S&P500 stocks are moving before the opening bell on Thursday?
↗
February 13, 2025
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via
Chartmill
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
February 13, 2025
Animal health company Zoetis (NYSE:ZTS) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue...
Via
StockStory
Zoetis Reports Fourth Quarter and Full Year 2024 Results
February 13, 2025
From
Zoetis Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
February 12, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
↗
January 07, 2025
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
December 12, 2024
Via
Benzinga
Earnings To Watch: Zoetis (ZTS) Reports Q4 Results Tomorrow
February 12, 2025
Animal health company Zoetis (NYSE:ZTS) will be reporting results tomorrow before market open. Here’s what to look for.
Via
StockStory
Looking to Grow Your Passive Income in 2025? 3 Top Dividend Growth Stocks to Double Up On Right Now
↗
February 08, 2025
Via
The Motley Fool
Zoetis Declares Second Quarter 2025 Dividend
February 06, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
February 04, 2025
From
Zoetis Inc.
Via
Business Wire
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
↗
January 17, 2025
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Via
The Motley Fool
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
January 07, 2025
From
Zoetis Inc.
Via
Business Wire
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
↗
December 22, 2024
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.
Via
Benzinga
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income
↗
December 19, 2024
Via
The Motley Fool
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
↗
December 13, 2024
Via
The Motley Fool
Topics
Stocks
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
December 12, 2024
From
Zoetis Inc.
Via
Business Wire
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
December 02, 2024
Via
Benzinga
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 19, 2024
From
Zoetis Inc.
Via
Business Wire
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent Pullback
↗
November 11, 2024
Zoetis looks like a classic example of a premium business trading at a fair price following its recent dip.
Via
The Motley Fool
Topics
Stocks
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
November 11, 2024
From
Zoetis Inc.
Via
Business Wire
Zoetis to Participate in Jefferies London Healthcare Conference
November 07, 2024
From
Zoetis Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.